Health Care & Life Sciences » Biotechnology | Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG | Mutual Funds

Mutual Funds that own Santhera Pharmaceuticals Holding AG

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
RFP Swiss Equity Plus
43,352
0.66%
0
0.96%
08/31/2018
CSIF Switzerland Total Market Index
35,021
0.54%
-531
0.01%
05/31/2018
UBS (CH) Equity Fund - Small Caps Switzerland
30,086
0.46%
0
0.15%
12/29/2017
UBS (CH) Institutional Fund - Small & Mid Cap Equities Switzer
21,598
0.33%
-8,475
0.04%
12/29/2017
16,250
0.25%
0
0.01%
12/29/2017
UBS (CH) Institutional Fund - Equities Switzerland Passive All
14,450
0.22%
0
0.01%
12/29/2017
ZKB - CIF Small & Mid Cap Index
14,373
0.22%
0
0.03%
07/31/2018
CSIF Switzerland Small & Mid Cap Index
13,106
0.2%
-46
0.03%
05/31/2018
Swisscanto (CH) SPI Index Fund
10,467
0.16%
0
0.01%
07/31/2018
ZKB - CIF Swiss Total Market Index
10,299
0.16%
0
0.01%
07/31/2018

About Santhera Pharmaceuticals Holding

View Profile
Address
Hohenrainstrasse 24
Pratteln Basel-Landschaft (Basle Country) 4133
Switzerland
Employees -
Website http://www.santhera.com
Updated 07/08/2019
Santhera Pharmaceuticals Holding AG is a pharmaceutical company. It engages in the development, marketing, and commercialization of pharmaceutical products for the treatment of neuro-ophthalmological, neuromuscular, and pulmonary diseases. It offers its products under the Raxone brands.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.